GW9508
Pharmaceutical compound
From Wikipedia, the free encyclopedia
GW9508 is an experimental drug which acts as a mixed agonist for the free fatty acid receptors FFAR1 (GPR40) and FFAR4 (GPR120). It is around 60x more potent as an agonist at FFAR1,[1] but has nevertheless often been used as a model agonist for FFAR4 especially in tissues which lack FFAR1 or in the presence of FFAR1 antagonists,[2] due to a historical lack of availability of highly selective FFAR4 agonists.[3] It has antiinflammatory effects[4][5][6] and has also been used to study the role of FFAR1 and FFAR4 in various processes such as regulation of insulin[7] and ghrelin[8] release, immune system function,[9][10] and maintenance of bone density.[11]
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.161.077 |
| Chemical and physical data | |
| Formula | C22H21NO3 |
| Molar mass | 347.414 g·mol−1 |
| 3D model (JSmol) | |
| |
| |